SNP Genotyping And Analysis Market Report 2026

SNP Genotyping And Analysis Market Overview

• SNP Genotyping And Analysis market size has reached to $18.5 billion in 2025 • Expected to grow to $46.29 billion in 2030 at a compound annual growth rate (CAGR) of 20.1% • Growth Driver: Growing Burden Of Genetic Diseases Fueling The Growth Of The Market Due To Enhanced Detection And Diagnosis Through Genetic Screening • Market Trend: Advanced Agricultural Whole Genome Sequencing Solution For Molecular Breeding Genotyping • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under SNP Genotyping And Analysis Market?

SNP genotyping and analysis refers to the identification and examination of single nucleotide polymorphisms-variations at a single base pair position in the genome-across individuals or populations, using molecular techniques such as PCR, microarrays, or sequencing. This process enables researchers to investigate genetic diversity, trace inheritance patterns, and understand individual differences in drug response or susceptibility to various conditions. The main types of samples in SNP genotyping and analysis are genomic DNA, ribonucleic acid (RNA), cell-free DNA (cfDNA), plasma samples, and whole blood. Genomic DNA is the whole collection of DNA found in an organism, carrying all of the genetic instructions required for its development and function. The tests are carried out using various technologies such as microarrays and gene chips, TaqMan allelic discrimination, SNP pyrosequencing, Applied Biosciences SNPlex, Sequenom MassArray MALDI-TOF, and others for various applications, including disease diagnostics, pharmacogenomics, precision medicine, forensic science, agriculture, and livestock. It caters to various end users, including hospitals and clinics, research laboratories, pharmaceutical and biotechnological companies, diagnostic laboratories, and academic and government institutions.

What Is The SNP Genotyping And Analysis Market Growth Forecast?

The snp genotyping and analysis market size is expected to see exponential growth in the next few years. It will grow to $46.29 billion in 2030 at a compound annual growth rate (CAGR) of 20.1%. The growth in the forecast period can be attributed to growth in personalized medicine, increased use of companion diagnostics, ai-driven genomic analytics, expansion of clinical genomics, government genomics initiatives. Major trends in the forecast period include expansion of precision medicine applications, rising adoption of pharmacogenomics, increased use of cfdna and liquid biopsy, growth of high-throughput genotyping platforms, integration of ai in genetic data analysis.

What Is The Driver Of The SNP Genotyping And Analysis Market?

The growing burden of genetic diseases is expected to propel the growth of the SNP genotyping and analysis market going forward. Genetic diseases are disorders caused by abnormalities in an individual's DNA, which may be inherited from one or both parents or arise due to mutations during cell division. The burden of genetic diseases is growing due to increasing awareness and improved diagnostic technologies, which have led to more diagnoses and a higher recognition of genetic disorders. SNP genotyping and analysis help in genetic diseases by identifying genetic variations associated with disease risk, progression, and drug response, enabling early diagnosis and personalized treatment. For instance, in February 2023, according to the World Health Organization, a Switzerland based international public health agency, congenital disorders were estimated to cause about 240,000 newborn deaths worldwide within the first 28 days of life each year, along with an additional 170,000 deaths among children aged 1 month to 5 years. Therefore, the growing burden of genetic diseases is driving the growth of the SNP genotyping and analysis industry.

Key Players In The Global SNP Genotyping And Analysis Market

Major companies operating in the snp genotyping and analysis market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Eurofins Genomics Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Life Sciences Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., Azenta Life Sciences Inc., LGC Limited, Invitae Corporation, Oxford Nanopore Technologies Limited, Standard BioTools Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Sophia Genetics SA, Genedata AG, Genotypic Technology Private Limited, PREMIER Biosoft International

Global SNP Genotyping And Analysis Market Trends and Insights

Major companies operating in the SNP genotyping and analysis market are focusing on developing technologically advanced solutions, such as agricultural large-scale low-pass whole genome sequencing, to address key challenges in molecular breeding genotyping of agricultural diploid species. Agricultural whole genome sequencing is the process of decoding the complete genetic material of crops or livestock to improve traits like yield, disease resistance, and environmental adaptability. For instance, in June 2024, MGI Tech, a China-based biotechnology company, launched a highly efficient whole workflow solution for agricultural large-scale low-pass whole genome sequencing (low-pass WGS). This solution includes an automated full-process product portfolio covering DNA extraction, library preparation, sequencing, and SNP & InDel calling, designed specifically for molecular breeding genotyping of agricultural diploid species. It features advanced automation platforms and utilizes MGI’s DNBSEQ-T7 and DNBSEQ-G400 sequencers to achieve ultra-high throughput and flexibility. The workflow also includes pig reference panels and data analysis software to facilitate genotyping without custom database creation.

What Are Latest Mergers And Acquisitions In The SNP Genotyping And Analysis Market?

In January 2023, QIAGEN N.V., a Germany-based provider of sample and assay technologies, acquired Verogen, Inc., for an undisclosed amount. Through this acquisition, QIAGEN aims to strengthen its leadership in human identification and forensics by integrating Verogen’s advanced NGS tools and bioinformatics solutions into its existing Sample to Insight portfolio. Verogen Inc., is a US-based biotechnology company that offers SNP genotyping and analysis through their forenseq kintelligence kit and universal analysis software.

What Defines the SNP Genotyping And Analysis Market?

The SNP genotyping and analysis market consists of revenues earned by entities by providing services such as DNA extraction and quality control, whole genome SNP analysis, SNP chip services, genetic association studies, and bioinformatics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The SNP genotyping and analysis market also includes sales of genotyping platforms, genotyping assays/kits, bioinformatics software, Axiom genome-wide arrays, and bioinformatics analysis tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the SNP Genotyping And Analysis Market Report 2026?

The snp genotyping and analysis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the snp genotyping and analysis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.